122
Views
2
CrossRef citations to date
0
Altmetric
Research Article

The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies

, , , , , & show all
Pages 642-647 | Received 20 Sep 2012, Accepted 27 Aug 2012, Published online: 12 Oct 2012

References

  • Vranken G, Reynolds T, Van Nueten J. Medians for second-trimester maternal serum markers: geographical differences and variation caused by median multiples-of-median equations. J Clin Pathol 2006;59:639–44.
  • Canick JA, Saller DN Jr, Lambert-Messerlian GM. Prenatal screening for Down syndrome: current and future methods. Clin Lab Med 2003;23:395–411.
  • Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. J Med Screen 1997; 4: 181–246.
  • Cuckle H. Antenatal screening for Down's syndrome. Lancet 1998;352:1144–5.
  • MacRae AR, Gardner HA, Allen LC, Tokmakejian S, Lepage N. Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application. Clin Chem 2003;49:69–76.
  • Reynolds TM, Vranken G, Van Nueten J, Aldis J. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters. Int J Clin Pract 2008;62:735–43.
  • Reynolds TM, Vranken G, Van Nueten J. Weight correction of MoM values: which method?J Clin Pathol 2006; 59: 753–8.
  • Wang YY, Luo J, Zhu MW, Liu LN, Ma X. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations. Int J Gynaecol Obstet 2006;94:67–72.
  • Wald NJ, Hackshaw AK, George LM. Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome. J Med Screen 2000;7:74–7.
  • Benn PA, Makowski GS, Egan JF, Wright D. Reproducibility of risk figures in 2nd-trimester maternal serum screening for Down syndrome: comparison of 2 laboratories. Clin Chem 2006;52:2087–94.
  • Neveux LM, Palomaki GE, Knight GJ, Haddow JE. Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn 1996;16:29–34.
  • Shamshirsaz AA, Benn P, Egan JF. The role of second-trimester serum screening in the post-first-trimester screening era. Clin Lab Med 2010;30:667–76.
  • Crandall BF, Lebherz TB, Schroth PC, Matsumoto M. Alphafetoprotein concentrations in maternal serum: relation to race and body weight. Clin Chem 1983;29:531–3.
  • Bogart MH, Jones OW, Felder RA, Best RG, Bradley L, Butts W, Crandall B, MacMahon W, Wians FH Jr, Loeh PV. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies. Am J Obstet Gynecol 1991;165:663–7.
  • Benn PA, Clive JM, Collins R. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Clin Chem 1997;43:333–7.
  • Beaman JM, Goldie DJ. Second trimester screening for Down's syndrome: 7 years experience. J Med Screen 2001; 8:128–31.
  • Mancini G, Perona M, Dall'Amisco CD. hCG, AFP, and uE3 patterns in the 14–20th weeks of Down's syndrome pregnancies. Prenat Diagn 1992;12:619–24.
  • Wang YY, Zhang L, Peng ZQ, Cui QZ, Ma X. Chinese weight-correction model for maternal serum markers in Down syndrome prenatal screening. Int J Gynaecol Obstet 2007;97:21–5.
  • Palomaki GE, Lee JE, Canick JA, McDowell GA, Donnenfeld AE; ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements. Genet Med 2009;11: 669–81.
  • Palomaki GE, Bradley LA, McDowell GA; Down Syndrome Working Group; ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines: prenatal screening for Down syndrome. Genet Med 2005;7: 344–54.
  • Benn PA, Collins R. Evaluation of analytical precision in maternal serum screening for Down syndrome. Ann Clin Biochem 2001;38:28–36.
  • Xia YP, Zhu MW, Li XT, Zhou HP, Wang J, Lv JX, Zhong N. Chromosomal abnormalities and adverse pregnancy outcome with maternal serum second trimester triple screening test for fetal Down syndrome in 4,860 Chinese women. Beijing Da Xue Xue Bao 2006;38:49–52.
  • Benn PA. Advances in prenatal screening for Down syndrome: general principles and second trimester testing. Clin Chim Acta 2002;323:1–16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.